Clinical trial • Phase I • Infectious Disease
Clinical trial in Healthy volunteers
Phase I trial for Healthy volunteers. 60 participants.
Overview
- Trial Therapeutic Area
- Infectious Disease
- Trial Disease
- Healthy volunteers
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 29-10-2024
- First CTIS Authorization Date
- 10-12-2024
Trial design
Phase I trial across 1 site in Belgium.
- Target Sample Size
- 60
Recruitment
- Planned Sample Size
- 60
- Recruitment Window Months
- 23
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 60
Belgium
- Earliest CTIS Part Ii Submission Date
- 29-11-2024
- Latest Decision Or Authorization Date
- 09-05-2025
- Processing Time Days
- 161
- Number Of Sites
- 1
- Number Of Participants
- 60
Sites
- Site Name
- Universitair Ziekenhuis Gent
- Department Name
- Head of Department CEVAC
- Principal Investigator Name
- Isabel Leroux-Roels
- Principal Investigator Email
- Isabel.LerouxRoels@UZGent.be
- Contact Person Name
- Isabel Leroux-Roels
- Contact Person Email
- Isabel.LerouxRoels@UZGent.be
- Number Of Participants
- 60
Sponsor
Primary sponsor
- Full Name
- Virometix AG
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Switzerland
Related trials
Other published trials that may interest you.